Other mechanisms, such as O^6-methylguanine-DNA methyltransferase (MGMT) hypermethylation, have a causative role, as this epigenetic modification is an important recurrent epigenetic event in GBM that is a factor responsible for chemotherapy resistance, its evaluation being routinely conducted in the clinic [15]. The gene discussed is MGMT; the disease is glioblastoma.